Chicago Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72M | Hold |
18,984
| – | – | 0.04% | 154 |
|
|
2026
Q1 | $1.52M | Sell |
18,984
-701
| -4% | -$57.8K | 0.04% | 161 |
|
|
2025
Q4 | $1.68M | Hold |
19,685
| – | – | 0.04% | 158 |
|
|
2025
Q3 | $1.53M | Sell |
19,685
-367
| -2% | -$28.7K | 0.04% | 157 |
|
|
2025
Q2 | $1.57M | Buy |
20,052
+81
| +0.4% | +$6.04K | 0.04% | 150 |
|
|
2025
Q1 | $1.45M | Buy |
19,971
+1,563
| +8% | +$112K | 0.04% | 143 |
|
|
2024
Q4 | $1.36M | Sell |
18,408
-83,763
| -82% | -$5.86M | 0.04% | 144 |
|
|
2024
Q3 | $6.74M | Sell |
102,171
-42,395
| -29% | -$3.08M | 0.19% | 73 |
|
|
2024
Q2 | $13.4M | Sell |
144,566
-2,159
| -1% | -$191K | 0.4% | 51 |
|
|
2024
Q1 | $14M | Sell |
146,725
-10,805
| -7% | -$908K | 0.43% | 47 |
|
|
2023
Q4 | $12M | Sell |
157,530
-18,829
| -11% | -$1.31M | 0.43% | 47 |
|
|
2023
Q3 | $12.2M | Sell |
176,359
-3,063
| -2% | -$246K | 0.57% | 43 |
|
|
2023
Q2 | $16.9M | Sell |
179,422
-997
| -0.6% | -$86.7K | 0.76% | 37 |
|
|
2023
Q1 | $14.9M | Sell |
180,419
-263,351
| -59% | -$20.7M | 0.74% | 37 |
|
|
2022
Q4 | $33.1M | Sell |
443,770
-47,241
| -10% | -$3.64M | 1.83% | 22 |
|
|
2022
Q3 | $40.6M | Sell |
491,011
-4,167
| -0.8% | -$401K | 2.35% | 14 |
|
|
2022
Q2 | $47.1M | Buy |
495,178
+29,062
| +6% | +$3.01M | 2.6% | 10 |
|
|
2022
Q1 | $54.9M | Buy |
466,116
+15,255
| +3% | +$1.71M | 2.36% | 12 |
|
|
2021
Q4 | $58.4M | Sell |
450,861
-6,205
| -1% | -$724K | 2.18% | 19 |
|
|
2021
Q3 | $51.7M | Sell |
457,066
-3,393
| -0.7% | -$387K | 1.96% | 22 |
|
|
2021
Q2 | $47.7M | Sell |
460,459
-875
| -0.2% | -$82.5K | 1.86% | 24 |
|
|
2021
Q1 | $38.6M | Buy |
461,334
+5,945
| +1% | +$503K | 1.63% | 30 |
|
|
2020
Q4 | $41.5M | Buy |
455,389
+107,585
| +31% | +$8.92M | 1.86% | 28 |
|
|
2020
Q3 | $27.8M | Buy |
347,804
+30
| +0% | +$2.34K | 1.43% | 31 |
|
|
2020
Q2 | $24M | Buy |
347,774
+3,992
| +1% | +$284K | 1.39% | 30 |
|
|
2020
Q1 | $21.6M | Sell |
343,782
-111,714
| -25% | -$8.06M | 1.74% | 24 |
|
|
2019
Q4 | $35.4M | Sell |
455,496
-11,229
| -2% | -$877K | 2.16% | 14 |
|
|
2019
Q3 | $34.2M | Sell |
466,725
-170,628
| -27% | -$12M | 2.29% | 8 |
|
|
2019
Q2 | $39.2M | Buy |
637,353
+22,287
| +4% | +$1.35M | 2.51% | 5 |
|
|
2019
Q1 | $39.2M | Sell |
615,066
-13,272
| -2% | -$757K | 2.67% | 5 |
|
|
2018
Q4 | $32.1M | Sell |
628,338
-4,332
| -0.7% | -$219K | 2.62% | 5 |
|
|
2018
Q3 | $36.7M | Buy |
632,670
+72,393
| +13% | +$3.54M | 2.54% | 6 |
|
|
2018
Q2 | $27.2M | Buy |
560,277
+178,176
| +47% | +$8.32M | 2.19% | 9 |
|
|
2018
Q1 | $17.8M | Buy |
+382,101
| New | +$16.6M | 2.37% | 10 |
|
Other funds holding EW
WT
BHIA
NONA
SIM
Chicago Capital's EW Position: Q2 2026 in Review
Chicago Capital held its Edwards Lifesciences (EW) position steady in Q2 2026 at 18,984 shares worth $1.72M. The position accounts for 0.04% of the portfolio, ranked #154.
Chicago Capital first reported a position in EW in Q1 2018 and has held it in 34 quarters since. The position peaked at $58.4M in Q4 2021. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Chicago Capital held 18,984 shares of Edwards Lifesciences worth $1.72M as of Q2 2026.
- Chicago Capital left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.04% of Chicago Capital's portfolio in Q2 2026, its #154 holding.
- Chicago Capital first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's Edwards Lifesciences position peaked at $58.4M in Q4 2021.
- 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.